Læknablaðið - 15.09.1998, Page 87

LÆKNABLAÐIÐ 1998; 84
701
Clinical Biochemistry and Molecular Medicine in
Current Oncology
Norrænt námskeið í Reykjavík 23.-26. september
Lectures, informal discussions, demonstrations, and practical laboratory experience.
The course will be held in English.
Topics: Review of the role of the clinical biochemistry laboratory in oncology. Special
emphasis will be on integration of novel insights in cancer biology with more traditional
methods. The course consists of lectures, laboratory demonstrations and group discus-
sion. Materials covered include molecular genetics of cancer, i.e. DNA repair defects and
genome instability. Familial cancer syndromes will be reviewed with focus on laboratory
workup in risk assessment, diagnosis and monitoring of treatment. We will address key
issues of current interest to the clinical biochemist such as comparison of biochemical
and molecular genetic tests with other diagnostic modalities and why clinicians and
patients consider tumor markers to be terror markers.
The course is primarily designed for physicians specializing in clinical biochemistry or
oncology in the Nordic countries. Young research scientists in oncology or related fields,
as well as fully qualified professionals working within the field or interested in the topic
may also attend. Newly qualified doctors are also invited to attend. The course will be limi-
ted to 40 participants. Registration fee is 10,000,- lcelandic krónur.
Host Faculty
1. Helgi Sigurðsson, MD, PhD: Aneuploidy and tumorproliferation as prognostic andpre-
dictive factors in cancer treatment
2. Hrafn Tulinius, MD, PhD: Epidemiology of cancer: Sources of information - Genetic
epidemiology
3. ísleifur Ólafsson, MD, PhD: Proteases in cancer
4. Jón Jóhannes Jónsson, MD, PhD: DNA metabolism and Malformation and cancer
syndromes
5. Jórunn Eyfjörð, D Phil: DNA repair and genome instability
6. Reynir Arngrímsson, MD, PhD: Ethics of cancer screening and councelling families
with cancer syndromes
7. Sigurður Björnsson, MD: Application of Tumor Markers in Clinical Oncology
8. Sigurður Ingvarsson, Dr Med Sc: Cell Cycle Control and Molecular Genetics of Colon
Cancer
9. Steinunn Thorlacius, BS: Molecular genetics of breast cancer
10. Vilhelmína Haraldsdóttir, MD: Tumor markers in hematological malignancies
Guest Faculty
1. David Sidransky, MD, Johns Hopkins, USA: Detection of mutated cells in body fluids
2. Diana Barnes, BSc, PhD, London, UK: Histochemical cancer markers
3. Simon Gayther, BSc, PhD, Cambridge, UK: Cancer genes overview
4. Ulf-Hákan Stenman, MD, PhD, Helsinki, F: Tumor markers
5. Unnur Pétursdóttir, MD, NIH, USA: Regulation of tumor neovascularization
ítariegri upplýsingar veitir Elín Ólafsdóttir læknir
Rannsóknastofu í meinefnafræði, Landspítalanum, 101 Reykjavík
Hún tekur einnig við umsóknum, sem senda má í pósti, með faxi eða í tölvupósti.
Sími: 560 1838, bréfsími: 560 1810, netfang: elino@rsp.is